Matthew R Sydes
University College London
H-index: 79
Europe-United Kingdom
Top articles of Matthew R Sydes
The SHOW RESPECT adaptable framework of considerations for planning how to share trial results with participants, based on qualitative findings from trial participants and site …
2024/4/30
Talia Isaacs
H-Index: 23
Matthew R Sydes
H-Index: 54
A new Trial Monitoring Plan (TMP) template for clinical trials: Output from a Delphi process
2024/4/29
Shiva Taheri
H-Index: 0
Victoria Yorke-Edwards
H-Index: 7
Matthew R Sydes
H-Index: 54
Talia Isaacs
H-Index: 23
Timing of Radiotherapy (RT) After Radical Prostatectomy (RP): Long-term outcomes in the RADICALS-RT trial [NCT00541047]
European Urology Supplements
2019/11/1
The Lancet Commission on prostate cancer: planning for the surge in cases
2024/4/4
Getting our ducks in a row: The need for data utility comparisons of healthcare systems data for clinical trials
Contemporary Clinical Trials
2024/3/26
Matthew R Sydes
H-Index: 54
Amanda Farrin
H-Index: 27
Fiona Lugg-Widger
H-Index: 5
Usha Menon
H-Index: 22
Victoria Yorke-Edwards
H-Index: 7
When to randomize patients in a randomized controlled trial?
2024/3/15
Matthew R Sydes
H-Index: 54
Jack Wilkinson
H-Index: 21
Prognostic impact of prostate-specific antigen at 6 months after radiotherapy in localized prostate cancer: an individual patient data analysis of randomized trials
Journal of Clinical Oncology
2024/3
Using healthcare systems data for outcomes in clinical trials: issues to consider at the design stage
Trials
2024/1/29
Protocol: Rationale and design of the THIRST Alert feasibility study: a pragmatic, single-centre, parallel-group randomised controlled trial of an interruptive alert for oral …
BMJ Open
2024
Rationale and design of the THIRST Alert feasibility study: a pragmatic, single-centre, parallel-group randomised controlled trial of an interruptive alert for oral fluid …
BMJ open
2024/1/1
A Repurposing Programme Evaluating Transdermal Oestradiol Patches for the Treatment of Prostate Cancer Within the PATCH and STAMPEDE Trials: Current Results and Adapting Trial …
Clinical Oncology
2024/1/1
Clinical testing of transcriptome-wide expression profiles in high-risk localized and metastatic prostate cancer starting androgen deprivation therapy: an ancillary study of …
Research Square
2023/2/8
Large-scale meta–genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types
JNCI Cancer Spectrum
2023/12/1
Elnaz Naderi
H-Index: 6
Leila Dorling
H-Index: 14
Tom Dudding
H-Index: 11
Joe Dennis
H-Index: 53
Jan Alsner
H-Index: 35
Andy Ness
H-Index: 61
Ananya Choudhury
H-Index: 2
Matthew R Sydes
H-Index: 54
Renée Bultijnck
H-Index: 8
Victoria Reyes
H-Index: 8
Chris Parker
H-Index: 7
Geoffrey Liu
H-Index: 4
Alison M Dunning
H-Index: 73
Christian Nicolaj Andreassen
H-Index: 17
Quantifying the carbon footprint of clinical trials: guidance development and pilot study
2023/5/19
PS8C-01 Agreement and completeness of routine versus trial-specific patient outcome data: a systematic review
2023/5/16
Matthew R Sydes
H-Index: 54
Qualitative data sharing practices in clinical trials in the UK and Ireland: towards the production of good practice guidance [version 1; peer review: awaiting peer review]
HRB open research
2023
Large-Scale Meta-GWAS Reveals Common Genetic Factors Linked to Radiation-Induced Acute Toxicities across Cancers
JNCI cancer spectrum
2023/12
Sequencing of androgen-deprivation therapy of short duration with radiotherapy for nonmetastatic prostate cancer (SANDSTORM): A pooled analysis of 12 randomized trials
Journal of Clinical Oncology
2023/2/1
Co-Authors
